Enabling Remote Patient Monitoring: Opportunities and Challenges at Bio2Device GroupPresentation

•

3 likes•1,343 views

Personal medical devices track an ever increasing amount of patient information away from the hospital. Coupled with quantitative self devices such as fitness trackers or calories counters, provide valuable information as the condition of a patient. Digital Health is growing a new realm of opportunities for biospace professionals. Yet challenges exist. Medical information software are archaic and siloed. Medical system is slow to adopt.

Enabling Remote Patient
Monitoring
Opportunities and Challenges

Akhsar Kharebov
akhsar@infometers.com

August 2013

Innovation focused on
solving acute problems

People live long lives, face
other risks

Chronic Conditions are
responsible for most deaths

Chronic Conditions are tied
to 75% of the costs

Management Traditionally
Provider Driven
Diagnosis, Treatment and Management

Top Down Approach
Doctors see patient at their ofﬁce

Expensive
Signiﬁcant Time from Medical Staff

Continuous Feedback
Annotating Everything

EMR not designed to
support remote monitoring

Low reimbursement for
monitoring or prevention

Development and
manufacturing costs have
dropped
At least for non-FDA devices…

Computational power has
grown dramatically

Data Represents Challenge
and Opportunity

Traditional Healthcare
Industry Stores

434 petabytes of data

“Right now we are giving you access to our
first version of the device as an exploratory
tool, where you are the researcher! By
helping us collect data, we can file our
application to the FDA for market approval
as an over-the-counter consumer-grade
diagnostic tool.”
Scanadu is not yet FDA
approved
http://www.indiegogo.com/projects/scanadu-scout-the-first-medical-tricorder

CrowdTesting Platform, IndieGoGo Partner
HealthTechHatch.com

A FEASIBILITY STUDY OF REMOTE MONITORING OF CAPD PATIENT’S BLOOD PRESSURE AND BLOOD GLUCOSE MEASUREMENTS VIA THE INTERNET. G. Pylypchuk, P. Jacobson, C. McAllister University of Saskatchewan, St. Paul’s Hospital, Saskatoon, Saskatchewan. Regina, Saskatchewan The purpose of this study was to determine the feasibility of remotely monitoring blood pressure (BP) and glucose measurements in a cohort of diabetic patients receiving continuous ambulatory peritoneal dialysis (CAPD).

Improving Quality And Reducing Cost In Healthcare The Role Of Information And...healthcareisi

Telemonitoring of older people

Roger Watson

Dr. Pappas describes the planning, implementation, and lessons learned of a Computerized Physician Order Entry (CPOE) launch at a small community hospital in Chicago, IL. He shares his experience as the director overseeing the project, its challenges and solutions. The goal of his presentation gives administrators, providers, and analysts information on what to expect when trying to implement CPOE and Health Information Systems.

Personal Health Records

Ayush Narula

Michael osborne

Samantha Haas

C te l-georgia partnership for telehealth march 2014Samantha Haas

6-005-1430-Rosenmannmed20su

Presentation eHealth-monitor - English

Myrah Wouters

Nr 650.kickoff powerpointnnorris1

ClickMedix Introduction and Case Studies 2014

ClickMedix

Quality Health Care: Technology and Data Drive Improvement by Stephen Lieber

Apollo Hospitals Group and ATNF

Early Sense

Health and Care Innovation Expo

Evaluating feasibility of Virtual Mentoring connecting an academic centre by ...

Apollo Hospitals Group and ATNF

Day in-the-life endo wide 2 with vidDavid Voran

US health care system overview 5nithinmohantk

What's hot

Roy Harper - Ulster HospitalCASALA CENTRE

Implementation of Online Safety Incident Reporting System in a Tertiary Care ...

Apollo Hospitals Group and ATNF

Shaping Informatics for Allied Health - Refining our voice

Health Informatics New Zealand

The Electronic Health Record:Using It Effectively & with Meaning

BU School of Medicine

Steven Heilman - mHealth in everyday practice

Plain Talk 2015

Insurance Patient Health Coordination ClickMedix 2015

ClickMedix

Virtual knowledge network NIMHANS Echo : Innovative tele- mentoring model for...

Apollo Hospitals Group and ATNF

Aust pharm march 2014

Paul Grundy

06 Am09 Presentations GutmanSimon Prince

Computerized Physician Order Entry: A Case Study

slvhit

Personal Health Records

Ayush Narula

Michael osborne

Samantha Haas

C te l-georgia partnership for telehealth march 2014Samantha Haas

6-005-1430-Rosenmannmed20su

Presentation eHealth-monitor - English

Myrah Wouters

Nr 650.kickoff powerpointnnorris1

ClickMedix Introduction and Case Studies 2014

ClickMedix

Quality Health Care: Technology and Data Drive Improvement by Stephen Lieber

Apollo Hospitals Group and ATNF

Early Sense

Health and Care Innovation Expo

Evaluating feasibility of Virtual Mentoring connecting an academic centre by ...

Apollo Hospitals Group and ATNF

What's hot (20)

Roy Harper - Ulster Hospital

Implementation of Online Safety Incident Reporting System in a Tertiary Care ...

Shaping Informatics for Allied Health - Refining our voice

The Electronic Health Record:Using It Effectively & with Meaning

Steven Heilman - mHealth in everyday practice

Insurance Patient Health Coordination ClickMedix 2015

Virtual knowledge network NIMHANS Echo : Innovative tele- mentoring model for...

Aust pharm march 2014

06 Am09 Presentations Gutman

Computerized Physician Order Entry: A Case Study

Personal Health Records

Michael osborne

C te l-georgia partnership for telehealth march 2014

6-005-1430-Rosenmann

Presentation eHealth-monitor - English

Nr 650.kickoff powerpoint

ClickMedix Introduction and Case Studies 2014

Quality Health Care: Technology and Data Drive Improvement by Stephen Lieber

Early Sense

Evaluating feasibility of Virtual Mentoring connecting an academic centre by ...

Similar to Enabling Remote Patient Monitoring: Opportunities and Challenges at Bio2Device GroupPresentation

Day in-the-life endo wide 2 with vidDavid Voran

US health care system overview 5nithinmohantk

Chronic illness: Wellness Solutions Personalized with Genomics & Biometrics

Shira Litwack Corporate Health Risk Assessments to incentives

Data drives company outcomes - employers agree analytics are a key factor in strategic planning. Customizing wellness solutions that has turned science fiction into science. Employees biometrics and genomics - sequencing the genome - drives choosing individualized wellness coaching. Health solutions - providing a path of sustainability and adherence - scientific, engaging, redefining individualized - And we make it affordable. Employee health programs - what a wonderful way to build healthier communities - establish lifestyle habits creating a healthier future for our children. We can manage & prevent chronic illnesses - saving lives and money - investing the money for happier, bigger, better futures.

Patient safetyMohamed Mosaad Hasan

A Vision for NZ Health Information

Health Informatics New Zealand

Reduce Your Health Insurance CostsMichael Sweeney

Chapter 4 Electronic Health RecordsRobert Hoyt MDVishnu Moh.docx

robertad6

Chapter 4: Electronic Health Records Robert Hoyt MD Vishnu Mohan MD After reading this chapter the reader should be able to: State the definition and history of electronic health records (EHRs) Describe the limitations of paper-based health records Identify the benefits of electronic health records List the key components of an electronic health record Describe the ARRA-HITECH programs to support EHRs Describe the benefits and challenges of computerized order entry and clinical decision support systems State the obstacles to purchasing, adopting and implementing an electronic health record Enumerate the steps to adopt and implement an EHR Learning Objectives 2 There is no topic in health informatics as important, yet controversial, as the electronic health record (EHR) In spite of fledgling EHRs being around for the past 35-40 years they are still controversial in the eyes of many Due to the federal government reimbursement programs for EHR use by physicians and hospitals, EHRs are now part of the healthcare landscape Some of the famous early EHRs are listed on the next slide Introduction The Problem Oriented Medical Information System (PROMIS) American Rheumatism Association Medical Information System (ARAMIS) Regenstrief Medical Record System (RMRS) Summary Time Oriented Record (STOR) Health Evaluation Through Logical Processing (HELP) Computer Stored Ambulatory Record (COSTAR) De-Centralized Hospital Computer Program (DHCP)—forerunner of VistA (Veterans Health Administration) Early EHRs Electronic Health Record: “An electronic record of health-related information on an individual that conforms to nationally recognized interoperability standards and that can be created, managed and consulted by authorized clinicians and staff across more than one healthcare organization” While the “experts” can debate the difference between EHR and EMR, we will not and will stick with EHR throughout the textbook and slides Definition Paper records are severely limited: less legible, more difficult to retrieve, store and share and unstructured data. Also, electronic records less likely to be missing and available 24/7 from multiple locations. Paper records do not permit clinical decision support Need for improved efficiency and productivity: clinicians are more productive if charts are available and retrieval of results is faster. EHR access from home while on call helps productivity Quality of care and patient safety: the factors already described in last two bullets plus clinical decision support, quality reports and secure messaging as part of an EHR Why do we need EHRs? Public expectations: EHRs may increase patient satisfaction through faster results, messaging, patient portals, electronic patient education, e-prescribing and online scheduling Governmental expectations: federal government considers EHR to be transformational and hence why they support reimbursement for u.

TelehealthLisa Raymond

Medical Records Privacy Confidentiality And SecurityAbbas Shojaee MD, CHDA

telemedicineppt.pptx

RiyaMathur18

What is a good app_Trappenburg 2.0Jaap Trappenburg PhD

CADR+ Pitch Book - 6-25-13CADRPlus

Becoming Better Advocates for Your Health

Best Doctors

A leader and innovator in research on patient-centered care, Dr. Leana Wen will share her perspectives on what patients and providers can do to work more effectively together to achieve their shared goal – better health and outcomes. She will be joined by Sonia Millsom, VP of Best Doctors, who will discuss how optimizing care and controlling costs are within reach for today’s patient. The presenters will finish with live questions from the audience.

Digital Medicine & The Future Preventative Healthcare

João Bocas

AMA Digital Health Study

Brian Ahier

Electronic health records

Syed Ali Raza

Wealth of Networks3GDR

healthcare quality and safety

Ahamed Masooth mohamed

Nursing education

preetihooda4

IIE June Conference R Blackwell

rblackwell46

Similar to Enabling Remote Patient Monitoring: Opportunities and Challenges at Bio2Device GroupPresentation (20)

Day in-the-life endo wide 2 with vid

US health care system overview 5

Chronic illness: Wellness Solutions Personalized with Genomics & Biometrics

Patient safety

A Vision for NZ Health Information

Reduce Your Health Insurance Costs

Chapter 4 Electronic Health RecordsRobert Hoyt MDVishnu Moh.docx

Telehealth

Medical Records Privacy Confidentiality And Security

telemedicineppt.pptx

What is a good app_Trappenburg 2.0

CADR+ Pitch Book - 6-25-13

Becoming Better Advocates for Your Health

Digital Medicine & The Future Preventative Healthcare

AMA Digital Health Study

Electronic health records

Wealth of Networks

healthcare quality and safety

Nursing education

IIE June Conference R Blackwell

Recently uploaded

Prix Galien International 2024 Forum Program

Levi Shapiro

June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels: - ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING - WOMEN’S HEALTH: FERTILITY PRESERVATION - WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? - ARTIFICIAL INTELLIGENCE AND ETHICS - GENE THERAPY - BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE - ETHICAL CHALLENGES IN LIFE SCIENCES - Prix Galien International Awards Ceremony

basicmodesofventilation2022-220313203758.pdf

aljamhori teaching hospital

24 Upakrama.pptx class ppt useful in all

DrSathishMS1

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf

DR SETH JOTHAM

The prostate is an exocrine gland of the male mammalian reproductive system It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ). It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes It’s work is regulated by androgens which are responsible for male sex characteristics Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Savita Shen $i11

heat stroke and heat exhaustion in children

SumeraAhmad5

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

VarunMahajani

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Flu Vaccine Alert in Bangalore Karnataka

addon Scans

As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions. Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says. This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots. To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare. Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself. Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places. Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages. Stay informed, stay safe, and get your flu shot today!

Physiology of Chemical Sensation of smell.pdf

MedicoseAcademics

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

micro teaching on communication m.sc nursing.pdf

Anurag Sharma

Cervical & Brachial Plexus By Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Ophthalmology Clinical Tests for OSCE exam

KafrELShiekh University

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

Catherine Liao

Antiulcer drugs Advance Pharmacology .pptx

Rohit chaurpagar

Anti ulcer drugs and their Advance pharmacology || Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining. ||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...

Savita Shen $i11

KDIGO 2024 guidelines for diabetologists

د.محمود نجيب

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

Saeid Safari

Recently uploaded (20)

Prix Galien International 2024 Forum Program

basicmodesofventilation2022-220313203758.pdf

24 Upakrama.pptx class ppt useful in all

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

heat stroke and heat exhaustion in children

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Flu Vaccine Alert in Bangalore Karnataka

Physiology of Chemical Sensation of smell.pdf

micro teaching on communication m.sc nursing.pdf

Cervical & Brachial Plexus By Dr. RIG.pptx

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Ophthalmology Clinical Tests for OSCE exam

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

Antiulcer drugs Advance Pharmacology .pptx

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...

KDIGO 2024 guidelines for diabetologists

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

Enabling Remote Patient Monitoring: Opportunities and Challenges at Bio2Device GroupPresentation

1. Enabling Remote Patient Monitoring Opportunities and Challenges

2. Akhsar Kharebov akhsar@infometers.com August 2013

4. Previously <200 years ago

5. People died young

7. Main cause of death was acute

8. Main cause of death was acute

9. Innovation focused on solving acute problems

10.

11. Dramatically increasing life

12.

13. Currently

14. People live long lives, face other risks

15. Chronic Conditions are responsible for most deaths

16.

17. Chronic Conditions are tied to 75% of the costs

18.

19. Require Monitoring and Management

20.

21. Management Traditionally Provider Driven Diagnosis, Treatment and Management

22. Top Down Approach Doctors see patient at their ofﬁce

23. Expensive Signiﬁcant Time from Medical Staff

24.

25. Limited Efﬁcacy Lifestyle unaffected

26. Future In Theory

27. Patient Choice

28. Ubiquitously Present Part of Your Life

29.

30. Continuous Feedback Annotating Everything

31.

32. Patient Driven Or at least engaged

33. Old and New Challenges

34. EMR not designed to support remote monitoring

35. Low reimbursement for monitoring or prevention

36. Federal Guidelines Still Unclear

37.

38. Technical adoption is slow in medicine

39. At the same time…

40. Development and manufacturing costs have dropped At least for non-FDA devices…

41. Computational power has grown dramatically

42.

43. Digital Health Data Next Big Frontier

44.

45. Devices Generate Most of the Data Today

46.

47. Data Represents Challenge and Opportunity

48. Traditional Healthcare Industry Stores 434 petabytes of data

49. Making Sense of it is Non Trivial

50.

51. Additionally

52. Personal Health Data is growing rapidly

53. Many self-monitoring options FDA & QS

54.

55. Examples

56. FitBit

57. Withings

58. BodyMedia & Jawbone

59. Basis

60. vimeo.com/ 45229049

61. Opportunities

62. Patient Monitoring

63. On sites like IndieGoGo Crowd Funding

64. $846,675 in preorders Misﬁt Shine

65.

66. $ 1,664,375 in preorders Scanadu

67.

68. Crowd Testing

69.

70. “Right now we are giving you access to our first version of the device as an exploratory tool, where you are the researcher! By helping us collect data, we can file our application to the FDA for market approval as an over-the-counter consumer-grade diagnostic tool.” Scanadu is not yet FDA approved http://www.indiegogo.com/projects/scanadu-scout-the-first-medical-tricorder

71. CrowdTesting Platform, IndieGoGo Partner HealthTechHatch.com

72. Personalized Diagnostic Services

73. Drug and Therapy Trials

74. New Delivery Vehicles and Devices

75. vimeo.com/ 45229049

76. New Distribution and Market Ecosystem

77.

78.

79. Summary

80. Challenges remain

81. A lot of new opportunities

82.